🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to contact these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with numerous of members share comparison images, injection guides and claims of next-day British shipping. Vendors market the substance there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting products of uncertain source.

Several professionals said the popularity for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, legal action or imprisonment.

Platform Reaction and Content Elimination

Based on TikTok, the service has taken down violative content and banned associated keywords and query recommendations. The organization stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Online Marketplace Operations

Research also found groups with up to nine thousand participants selling retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, filled with images of weight loss, positive reviews and detailed guides for preparing or administering at home.

After moments of entering one community, a vendor posted WhatsApp details, where the majority of transactions occur. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Within these groups, posts display black plastic parcels with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When questioned how much time a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service stated it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is sound, these online products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has previously seen individuals injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may expose users to potentially serious health risks”.